14.10.2015
- US drugmaker Johnson & Johnson (J&J), the country’s largest healthcare company, in particular in the consumer segment, has launched a $10 billion debt-financed share buyback...
15.04.2015
- Swedish drugmaker Recipharm has acquired $2 million worth of preferred stock in Synthonics and has promised to buy an additional $2 million of the stock, contingent on the US metal...
